Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BATM Advanced CommunicationsLSE:BVC 33 Intrinsic Value: Projected FCF is £0.08 as of Sep. 05, 2026. GuruFocus rates LSE:BVC with a GF Score™ of 33/100 and a GF Value™ of £0.15 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 415 Medical Devices & Instruments companies, BATM Advanced Communications ranks better than 51.08% on this metric.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
The historical rank and industry rank for BATM Advanced Communications's Intrinsic Value: Projected FCF or its related term are showing as below:
LSE:BVC'
s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 1.01 Med: 2.62 Max: 5.81
Current: 1.47
During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of BATM Advanced Communications was 5.81. The lowest was 1.01. And the median was 2.62.
LSE:BVC's Price-to-Projected-FCF is ranked better than 51.08% of 415
companies
in the Medical Devices & Instruments industry
Industry Median: 1.49
vs LSE:BVC: 1.47
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
BATM Advanced Communications's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF
=
Share Price
/
Intrinsic Value: Projected FCF
=
0.1175
/
0.08423098855463
=
1.39
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BATM Advanced Communications Intrinsic Value: Projected FCF Related Terms
BATM Advanced Communications Intrinsic Value: Projected FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:BVC vs ISRG, BDX, RMD: Intrinsic Value: Projected FCF Comparison
For the Medical Instruments & Supplies subindustry, BATM Advanced Communications's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BATM Advanced Communications Price-to-Projected-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BATM Advanced Communications's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where BATM Advanced Communications's Price-to-Projected-FCF falls into.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Intrinsic Value: Projected FCF of £0.08 mean?
BATM Advanced Communications (LSE:BVC) has a Intrinsic Value: Projected FCF of £0.08 as of Sep. 05, 2026. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on BATM Advanced Communications and its competitors. According to the industry distribution chart, BATM Advanced Communications ranks #203 out of 415 companies in the Medical Devices & Instruments industry, placing it in the top 48.9%.
Is BATM Advanced Communications' Intrinsic Value: Projected FCF too high?
BATM Advanced Communications' current Intrinsic Value: Projected FCF is £0.08. Based on the distribution chart, BATM Advanced Communications ranks #203 out of 415 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, BATM Advanced Communications has a GF Score™ of 33/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BATM Advanced Communications' Intrinsic Value: Projected FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, BATM Advanced Communications ranks #203 out of 415 companies for Intrinsic Value: Projected FCF. This puts BATM Advanced Communications in the upper half of its industry. The industry median Intrinsic Value: Projected FCF is 1.49. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Intrinsic Value: Projected FCF for a Medical Devices & Instruments company?
The median Intrinsic Value: Projected FCF among Medical Devices & Instruments companies is 1.49, based on 415 companies in the industry. Companies in the top quartile (top 25%) have a Intrinsic Value: Projected FCF significantly above this median, while those in the bottom quartile fall well below. However, Intrinsic Value: Projected FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Intrinsic Value: Projected FCF mean?
A high Intrinsic Value: Projected FCF can signal that a stock is expensive relative to its fundamentals. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on BATM Advanced Communications and its competitors. For the Medical Devices & Instruments industry, the median Intrinsic Value: Projected FCF is 1.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BATM Advanced Communications's current Intrinsic Value: Projected FCF is £0.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BATM Advanced Communications stock overvalued right now?
Based on GuruFocus' analysis, BATM Advanced Communications (LSE:BVC) is currently considered Modestly Undervalued. The stock's GF Value™ is £0.15, compared to a current price of £0.12 — trading 21.7% below its estimated fair value. The current Intrinsic Value: Projected FCF is £0.08. BATM Advanced Communications' overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Intrinsic Value: Projected FCF calculated?
Intrinsic Value: Projected FCF is calculated from a company's financial statements. For BATM Advanced Communications (LSE:BVC), the current Intrinsic Value: Projected FCF is £0.08 as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BATM Advanced Communications (LSE:BVC) Overvalued in 2026?
Based on GuruFocus' analysis, BATM Advanced Communications stock appears to be undervalued.
The current stock price of £0.12 is trading 21.7% below its estimated GF Value™ of £0.15.
GuruFocus considers BATM Advanced Communications to be Modestly Undervalued.
Key valuation signals for LSE:BVC:
Intrinsic Value: Projected FCF: £0.08
GF Value™: £0.15 vs. price of £0.12 (21.7% below fair value)
No single metric tells the full story. See the LSE:BVC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BATM Advanced Communications Ltd is an Israel-based technology company. It is engaged in the development, production and supply of real-time technologies and associated services in three core application areas: Networks, Cyber and Diagnostics. In addition, the Group's non-core activities comprised the production and supply of pharmaceutical applications and the distribution of third-party pharmaceutical and environmental monitoring products. The company organizes its business operations into three divisions: Networking, Cyber Division, and Diagnostics Division. It generates majority of revenue from Diagnostics mainly engaged in sales and distribution of in vitro diagnostics reagents and instruments. It operates in three geographical areas: the United States of America, Israel and Europe.
33GF Score
Get the complete analysis for LSE:BVC
Intrinsic Value: Projected FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:BVC has been successfully added to your 
